245 related articles for article (PubMed ID: 16009172)
1. Polymorphism of the p53 tumor suppressor gene is associated with susceptibility to uterine leiomyoma.
Denschlag D; Bettendorf H; Watermann D; Keck C; Tempfer C; Pietrowski D
Fertil Steril; 2005 Jul; 84(1):162-6. PubMed ID: 16009172
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor-alpha-308 promoter and p53 codon 72 gene polymorphisms in women with leiomyomas.
Hsieh YY; Chang CC; Tsai FJ; Lin CC; Yeh LS; Tsai CH
Fertil Steril; 2004 Oct; 82 Suppl 3():1177-81. PubMed ID: 15474092
[TBL] [Abstract][Full Text] [Related]
3. Four novel single nucleotide polymorphisms within the promoter region of p53 gene and their associations with uterine leiomyoma.
Hsieh YY; Wang JP; Lin CS
Mol Reprod Dev; 2007 Jul; 74(7):815-20. PubMed ID: 17186536
[TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor alpha polymorphism and susceptibility to uterine leiomyoma.
Villanova FE; Andrade PM; Otsuka AY; Gomes MT; Leal ES; Castro RA; Girão MJ; Nishimura E; Baracat EC; Silva ID
Steroids; 2006 Nov; 71(11-12):960-5. PubMed ID: 16935316
[TBL] [Abstract][Full Text] [Related]
5. The progesterone receptor gene polymorphism, PROGINS, may be a factor related to the development of uterine fibroids.
Gomes MT; Castro Rde A; Villanova FE; da Silva ID; Baracat EC; de Lima GR; Girão MJ
Fertil Steril; 2007 May; 87(5):1116-21. PubMed ID: 17224149
[TBL] [Abstract][Full Text] [Related]
6. Uterine leiomyoma is associated with a polymorphism in the interleukin 1-beta gene.
Pietrowski D; Thewes R; Sator M; Denschlag D; Keck C; Tempfer C
Am J Reprod Immunol; 2009 Aug; 62(2):112-7. PubMed ID: 19614627
[TBL] [Abstract][Full Text] [Related]
7. Polymorphism at codon 72 of the p53 gene is not associated with endometriosis in a Japanese population.
Omori S; Yoshida S; Kennedy SH; Negoro K; Hamana S; Barlow DH; Maruo T
J Soc Gynecol Investig; 2004 May; 11(4):232-6. PubMed ID: 15120697
[TBL] [Abstract][Full Text] [Related]
8. p53 and p21 genetic polymorphisms and susceptibility to endometrial cancer.
Roh JW; Kim JW; Park NH; Song YS; Park IA; Park SY; Kang SB; Lee HP
Gynecol Oncol; 2004 May; 93(2):499-505. PubMed ID: 15099969
[TBL] [Abstract][Full Text] [Related]
9. The p21 codon 31*C- and DRD2 codon 313*T-related genotypes/alleles, but not XRCC1 codon 399, hOGG1 codon 326, and DRD1-48 polymorphisms, are correlated with the presence of leiomyoma.
Hsieh YY; Chang CC; Bau DT; Tsai FJ; Tsai CH; Chen CP
Fertil Steril; 2009 Mar; 91(3):869-77. PubMed ID: 19176223
[TBL] [Abstract][Full Text] [Related]
10. Lack of evidence that proline homozygosity at codon 72 of p53 and rare arginine allele at codon 31 of p21, jointly mediate cervical cancer susceptibility among Indian women.
Bhattacharya P; Sengupta S
Gynecol Oncol; 2005 Oct; 99(1):176-82. PubMed ID: 16054204
[TBL] [Abstract][Full Text] [Related]
11. Association of p53 polymorphisms with breast cancer: a case-control study in Slovak population.
Franeková M; Zúbor P; Stanclová A; Dussan CA; Bohusová T; Galo S; Dobrota D; Kajo K; Péc M; Racay P
Neoplasma; 2007; 54(2):155-61. PubMed ID: 17319790
[TBL] [Abstract][Full Text] [Related]
12. Single nucleotide polymorphisms in the progesterone receptor gene and association with uterine leiomyoma tumor characteristics and disease risk.
Renner SP; Strick R; Fasching PA; Oeser S; Oppelt P; Mueller A; Beckmann MW; Strissel PL
Am J Obstet Gynecol; 2008 Dec; 199(6):648.e1-9. PubMed ID: 18691687
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-6 -174G/C polymorphism in breast cancer and uterine leiomyoma patients: a population-based case control study.
Litovkin KV; Domenyuk VP; Bubnov VV; Zaporozhan VN
Exp Oncol; 2007 Dec; 29(4):295-8. PubMed ID: 18199986
[TBL] [Abstract][Full Text] [Related]
14. Is genetic polymorphism of ER-α, CYP1A1, and CYP1B1 a risk factor for uterine leiomyoma?
El-Shennawy GA; Elbialy AA; Isamil AE; El Behery MM
Arch Gynecol Obstet; 2011 Jun; 283(6):1313-8. PubMed ID: 20559649
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase-1 and -9 promoter polymorphisms are not associated with an increased risk of uterine leiomyomas in a Japanese population.
Takemura N; Yoshida S; Kennedy S; Deguchi M; Ohara N; Maruo T
J Soc Gynecol Investig; 2006 Apr; 13(3):232-6. PubMed ID: 16638593
[TBL] [Abstract][Full Text] [Related]
16. Germline polymorphism of p53 codon 72 in gynecological cancer.
Ueda M; Terai Y; Kanda K; Kanemura M; Takehara M; Yamaguchi H; Nishiyama K; Yasuda M; Ueki M
Gynecol Oncol; 2006 Jan; 100(1):173-8. PubMed ID: 16168468
[TBL] [Abstract][Full Text] [Related]
17. COX2 and p53 risk-alleles coexist in COPD.
Arif E; Vibhuti A; Deepak D; Singh B; Siddiqui MS; Pasha MA
Clin Chim Acta; 2008 Nov; 397(1-2):48-50. PubMed ID: 18692035
[TBL] [Abstract][Full Text] [Related]
18. No relationship observed between human p53 codon-72 genotype and HPV-associated cervical cancer in a population group with a low arginine-72 allele frequency.
Govan VA; Loubser S; Saleh D; Hoffman M; Williamson AL
Int J Immunogenet; 2007 Jun; 34(3):213-7. PubMed ID: 17504512
[TBL] [Abstract][Full Text] [Related]
19. p53 Codon 72 polymorphism predicts the pathologic response to neoadjuvant chemotherapy in patients with breast cancer.
Xu Y; Yao L; Ouyang T; Li J; Wang T; Fan Z; Lin B; Lu Y; Xie Y
Clin Cancer Res; 2005 Oct; 11(20):7328-33. PubMed ID: 16243804
[TBL] [Abstract][Full Text] [Related]
20. X-ray repair cross-complementing group 4 (XRCC4) promoter -1394( *)T-related genotype, but not XRCC4 codon 247/intron 3 or xeroderma pigmentosum group D codon 312, 751/promoter -114, polymorphisms are correlated with higher susceptibility to myoma.
Hsieh YY; Chang CC; Bau DT; Yeh LS; Tsai FJ; Tsai CH
Fertil Steril; 2008 Oct; 90(4 Suppl):1417-23. PubMed ID: 18177646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]